69P PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer
Abstract
Biliary tract cancer (BTC) is associated with poor prognosis because of its aggressive and heterogeneous nature. Programmed death ligand 1 (PD-L1) has been considered as a novel biomarker for prognosis and response of immune checkpoint inhibitors (CPIs) in various tumors. However, there are limited data reporting on the role of PD-L1 in advanced BTC patients. We analyzed 186 patients with advanced BTC who received palliative gemcitabine and...
Paper Details
Title
69P PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer
Published Date
Sep 1, 2020
Journal
Volume
31
Pages
S267 - S267
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History